VINC
Vanguard Group’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,317
| Closed | -$7.57K | – | 4374 |
|
|
2025
Q1 | $7.57K | Sell |
14,317
-272,055
| -95% | -$144K | ﹤0.01% | 4263 |
|
|
2024
Q4 | $75.3K | Sell |
286,372
-341,070
| -54% | -$89.7K | ﹤0.01% | 4186 |
|
|
2024
Q3 | $449K | Hold |
627,442
| – | – | ﹤0.01% | 4001 |
|
|
2024
Q2 | $508K | Sell |
627,442
-39,553
| -6% | -$32K | ﹤0.01% | 3996 |
|
|
2024
Q1 | $3.37M | Buy |
666,995
+153,575
| +30% | +$777K | ﹤0.01% | 3433 |
|
|
2023
Q4 | $606K | Hold |
513,420
| – | – | ﹤0.01% | 3977 |
|
|
2023
Q3 | $519K | Sell |
513,420
-6,849
| -1% | -$6.92K | ﹤0.01% | 4042 |
|
|
2023
Q2 | $676K | Hold |
520,269
| – | – | ﹤0.01% | 4026 |
|
|
2023
Q1 | $541K | Hold |
520,269
| – | – | ﹤0.01% | 4107 |
|
|
2022
Q4 | $531K | Sell |
520,269
-1,887
| -0.4% | -$1.93K | ﹤0.01% | 4081 |
|
|
2022
Q3 | $720K | Sell |
522,156
-57,269
| -10% | -$79K | ﹤0.01% | 4101 |
|
|
2022
Q2 | $765K | Sell |
579,425
-86,594
| -13% | -$114K | ﹤0.01% | 4172 |
|
|
2022
Q1 | $2.66M | Buy |
666,019
+11,667
| +2% | +$46.7K | ﹤0.01% | 3834 |
|
|
2021
Q4 | $6.67M | Buy |
654,352
+119,317
| +22% | +$1.22M | ﹤0.01% | 3450 |
|
|
2021
Q3 | $8.65M | Buy |
535,035
+54,977
| +11% | +$889K | ﹤0.01% | 3335 |
|
|
2021
Q2 | $6.24M | Buy |
480,058
+90,069
| +23% | +$1.17M | ﹤0.01% | 3475 |
|
|
2021
Q1 | $7.53M | Buy |
+389,989
| New | +$7.53M | ﹤0.01% | 3315 |
|